[1]Capital Medical University China, School of Public Health,Beijing,China
[2]National Cancer Institute, Virus Tumor Biology Section,Bethesda,United States
[3]Fudan University, School of Life Sciences,Shanghai,China
[4]s Hospital,Hangzhou,China
[5]Zhejiang University, Department of Gynecologic Oncology,Hangzhou,China
[6]West China Hospital, Department of Obstetrics and Gynecology,Chengdu,China
Human papillomavirus type 58 (HPV58) is relatively prevalent in China and other Asian countries. In this study, the HPV58 genome in cervical lesions was decoded from five grade 2 or 3 cervical intraepithelial neoplasia lesion (CIN2/3) samples and five cervical cancer tissues using rolling-circle amplification of total cell DNA and deep sequencing and verified by whole-genome cloning and sequencing. HPV58 isolates from China feature a total of 52 nucleotide substitutions (0.66%) from the reference HPV58 sequence, which appear mainly in two regions, with 12 from nucleotides (nt) 3430 to 4136 covering the E2/E4/E5 open reading frames (ORFs) and 13 from nt 4621 to 5540 covering the L2 ORF; these could be grouped as HPV58 Chinese Zhejiang-1, -2, and -3 (CNZJ-1, -2, and -3) according to their sequence similarities and restriction enzyme digestion. Phylogenetically, CNZJ-3 is similar to the reference HPV58 sublineage A1 sequence. The other two are close to sublineage A2. Analysis of cervical lesion-derived RNA revealed abundant HPV58 early transcripts spliced at the E6 and E1/E2 ORFs, where two 5= splice sites at nt 232 and nt 898 and two 3= splice sites at nt 510 and nt 3355 can be identified. Thus, our study represents the first genome-wide analysis of HPV58 and its expression in cervical lesions. © 2013, American Society for Microbiology.
(8.0+极速模式)